Insider Transactions in Q3 2024 at Fennec Pharmaceuticals Inc. (FENC)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2024
|
Rosty Raykov |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+3.41%
|
-
|
|
Sep 30
2024
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
1,042
+0.93%
|
-
|
|
Sep 04
2024
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
2,431
-3.53%
|
$12,155
$5.52 P/Share
|
|
Aug 31
2024
|
Rosty Raykov |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+3.41%
|
-
|
|
Aug 31
2024
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
1,042
+0.94%
|
-
|
|
Aug 23
2024
|
Rosty Raykov |
SELL
Bona fide gift
|
Direct |
95,038
-20.76%
|
-
|
|
Aug 01
2024
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
2,431
-1.28%
|
$14,586
$6.25 P/Share
|
|
Jul 31
2024
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
1,042
+0.95%
|
-
|
|
Jul 31
2024
|
Rosty Raykov |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+1.26%
|
-
|
|
Jul 05
2024
|
Chris A Rallis |
SELL
Open market or private sale
|
Direct |
1,173
-2.46%
|
$7,038
$6.03 P/Share
|
|
Jul 05
2024
|
Chris A Rallis |
BUY
Exercise of conversion of derivative security
|
Direct |
1,792
+3.63%
|
$3,584
$2.79 P/Share
|
|
Jul 02
2024
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
2,431
-1.28%
|
$14,586
$6.13 P/Share
|
|
Jul 01
2024
|
Rosty Raykov |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+1.26%
|
-
|
|
Jul 01
2024
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
1,042
+0.96%
|
-
|